Santa Ana Bio
PrivateLast Round
Series A
Jun 13, 2024
Total Funding Raised
$168M
Company Overview
Santa Ana Bio operates in Healthcare & Life Sciences and is based in Alameda, California. Its latest recorded funding round was a Series A round in June 2024.
Santa Ana Bio is a biotechnology company that develops precision immunology solutions for autoimmune and inflammatory diseases using single-cell genomics and advanced analytics to create targeted biologics.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Santa Ana Bio Comparables
Compare Santa Ana Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Beeline Medicines | 86% | |
| Seismic | 83% | |
| Lifordi Immunotherapeutics, Inc. | 83% |
For institutional investors. Book with your work email.
Santa Ana Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jun 13, 2024 | ||||
| Series B | Jun 13, 2024 |
For institutional investors. Book with your work email.
Santa Ana Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Andreessen Horowitz | Series B |
| GV | Series A, Series B |
| Versant Ventures | Series B, Series A |
| RTW Investments | Series B |
| Access Biotechnology | Series B |
| TPG | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 13, 2024
$43M round led by Versant Ventures
- Jun 13, 2024
$125M round led by GV
For institutional investors. Book with your work email.
Santa Ana Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Santa Ana Bio's valuation, stock price, and market status.
Is Santa Ana Bio a public or private company?
Santa Ana Bio is a private company.
What is the current stock price of Santa Ana Bio?
Santa Ana Bio is a private company, so its shares have no public market price. Caplight tracks Santa Ana Bio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Santa Ana Bio worth (valuation)?
Valuation information for Santa Ana Bio is not publicly available.
Can I buy Santa Ana Bio stock?
Santa Ana Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Santa Ana Bio's last funding round?
Santa Ana Bio's most recent funding round was Series A on June 13, 2024.
Who are the main investors in Santa Ana Bio?
Key investors in Santa Ana Bio include GV, Versant Ventures.
Will Santa Ana Bio IPO soon?
No public IPO plans have been announced for Santa Ana Bio.
How can I track Santa Ana Bio secondary market activity?
Caplight tracks bids, offers, and trades in Santa Ana Bio's shares on secondary markets.